Company Novogene Co., Ltd.

Equities

688315

CNE1000052X3

Healthcare Facilities & Services

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Novogene Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Medical & Diagnostic Laboratories

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
13.24 ^CNY	-0.90%		+3.60%	-43.27%

Apr. 12	Novogene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 27	Novogene Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Novogene Co Ltd is a China-based company principally engaged in gene sequencing. The Company mainly relies on high-throughput sequencing technology and bioinformatics analysis technology to establish gene sequencing platforms. Combined with multi-omics research technology, the Company provides multi-level scientific and research technical services and solutions for life science basic research, medical and clinical application research. Based on the technology accumulation in gene sequencing and its application fields, the Company independently develops genetic testing medical equipment. The Company's services mainly include life science basic scientific research services, medical research and technical services, and database-building sequencing platform services. Its other services and products include gene mutation detection kits, coronavirus disease nucleic acid test service and DA8600 sequencers. The Company conducts its businesses in domestic and overseas markets.

Number of employees: 2,144

CNY in Million	2022	Weight	2023	Weight	Delta
Sequencing Platform Service 47.6 %	835	43.4 %	953	47.6 %	+14.05%
Life Science Basic Research Services 31.7 %	642	33.3 %	636	31.7 %	-0.94%
Medical Research and Technical Services 13.4 %	253	13.1 %	269	13.4 %	+6.60%
Other 7.0 %	195	10.1 %	140	7.0 %	-28.28%
Other Business 0.2 %	1	0.0 %	5	0.2 %	+436.74%

CNY in Million	2022	Weight	2023	Weight	Delta
China 50.8 %	1,118	58.1 %	1,017	50.8 %	-9.02%
Hong Kong, Macau,Taiwan and Overseas 49.2 %	807	41.9 %	985	49.2 %	+22.06%

Managers	Title	Age	Since
Rui Qiang Li CEO	Chief Executive Officer	44	11-03-14
Shi Shan Shi DFI	Director of Finance/CFO	42	14-03-31
Qi Feng Wang BRD	Director/Board Member	46	12-01-31

Members of the board	Title	Age	Since
Rui Qiang Li CEO	Chief Executive Officer	44	11-03-14
Qi Feng Wang BRD	Director/Board Member	46	12-01-31
Chun Fei Wang BRD	Director/Board Member	44	22-06-14
Quan Gan BRD	Director/Board Member	48	22-06-14
Xing Yuan Li CHM	Chairman	35	22-06-14
Ni Jia Feng BRD	Director/Board Member	30	22-06-14
Ping Li BRD	Director/Board Member	44	22-06-14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	416,200,000	97,615,459 ( 23.45 %)	0	23.45 %

Name	Equities	%	Valuation
SDIC Innovation Investment Management Co. Ltd. 9.339 %	10,263,718	9.339 %	20 M ¥
Zhong Ou Asset Management Co., Ltd 8.948 %	9,834,913	8.948 %	19 M ¥
Hongshan 8.671 %	9,530,596	8.671 %	19 M ¥
Zhi Jiang 7.732 %	8,497,744	7.732 %	17 M ¥
Penghua Fund Management Co., Ltd. 7.287 %	8,008,775	7.287 %	16 M ¥
Harfor Fund Management Co., Ltd. 4.880 %	5,363,909	4.880 %	10 M ¥
Bosera Asset Management Co., Ltd. 4.739 %	5,208,434	4.739 %	10 M ¥
Orient Securities Asset Management Co. Ltd. 4.224 %	4,642,974	4.224 %	9 M ¥
GF Fund Management Co., Ltd. 3.062 %	3,365,527	3.062 %	7 M ¥
Yinhua Fund Management Co., Ltd. 0.8777 %	964,675	0.8777 %	2 M ¥

Name	Equities	%	Valuation
Rui Qiang Li 92.21 %	282,429,740	92.21 %	553 M ¥
SDIC Innovation Investment Management Co. Ltd. 2.567 %	7,862,743	2.567 %	15 M ¥
Nuode Asset Management Co., Ltd. 1.057 %	3,236,994	1.057 %	6 M ¥
Zhong Ou Asset Management Co., Ltd 0.7840 %	2,401,257	0.7840 %	5 M ¥
Caitong Fund Management Co., Ltd. 0.6479 %	1,984,585	0.6479 %	4 M ¥
CHINESE UNIVERSE PUBLISHING AND MEDIA GROUP CO., LTD. 0.6291 %	1,926,782	0.6291 %	4 M ¥
Huatai Asset Management Co., Ltd. 0.6291 %	1,926,782	0.6291 %	4 M ¥
Chongqing Environmental Protection Industry Private Equity 0.4704 %	1,440,751	0.4704 %	3 M ¥
GF Fund Management Co., Ltd. 0.3145 %	963,391	0.3145 %	2 M ¥

Novogene Co., Ltd.

Room 101, Building 301, Yard 10 Jiuxianqiao North Road

100015, Beijing

http://www.novogene.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

13.24 CNY

Average target price

21.48 CNY

Spread / Average Target

+62.26%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
NOVOGENE CO., LTD.	-43.27%	762M
SONIC HEALTHCARE LIMITED	-16.65%	8.36B
RADNET, INC.	+39.98%	3.6B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-32.00%	2.87B
SYNLAB AG	-7.71%	2.47B
DR. LAL PATHLABS LIMITED	-9.65%	2.24B
NEOGENOMICS, INC.	-13.29%	1.81B
FLEURY S.A.	-19.46%	1.56B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.57%	1.23B
METROPOLIS HEALTHCARE LIMITED	+9.70%	1.13B

Medical & Diagnostic Laboratories